SCHEMBL4072775

SCHEMBL4072775

CC(C)(C)NC(=O)N1CCCCC1C(=O)N1CCCCC1

nearest known ligand 0.56

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
WNT3 P56703 1/20 0.45
SFRP1 Q8N474 1/20 0.45
LMNA P02545 1/20 0.44
HSD17B10 Q99714 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12788624 0.81 HSD17B10 (0.46) HSD17B10
SCHEMBL3612934 0.78
SCHEMBL13873135 0.77 ALDH1A1 (0.53) LMNAHSD17B10
SCHEMBL3174166 0.77 LMNA (0.55) LMNAHSD17B10
SCHEMBL4898833 0.77 LMNA (0.55) LMNAHSD17B10
SCHEMBL4019094 0.76 HPGD (0.50)
SCHEMBL5520943 0.76 HSD17B10 (0.45) HSD17B10
SCHEMBL13887670 0.76 HSD17B10 (0.50) HSD17B10
SCHEMBL22455535 0.76 F2 (0.49) LMNAHSD17B10
SCHEMBL7680329 0.76 LMNA (0.44) WNT3SFRP1LMNAHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2038041-A2 THERAPEUTIC COMPOUNDS AND THEIR USE IN CANCER Myriad Genetics, Inc. (US) 2009-03-25 EP disclosed
WO-2007134298-A2 THERAPEUTIC COMPOUNDS AND THEIR USE IN CANCER MYRIAD GENETICS, INC. (US) 2007-11-22 WO disclosed